Evidence map›Paper›PMID 33110114›Full record

ArticleScientific reports2020

SARS-Cov-2 trajectory predictions and scenario simulations from a global perspective: a modelling study.

Tianan Yang, Yexin Liu, Wenhao Deng, Weigang Zhao, Jianwei Deng

Abstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tianan YangSchool of Management and Economics, Beijing Institute of Technology, Beijing, China.
Yexin LiuSchool of Management and Economics, Beijing Institute of Technology, Beijing, China.
Wenhao DengSchool of Management and Economics, Beijing Institute of Technology, Beijing, China.
Weigang ZhaoSchool of Management and Economics, Beijing Institute of Technology, Beijing, China.
Jianwei DengSchool of Management and Economics, Beijing Institute of Technology, Beijing, China. dengjianwei2006@163.com.

Funding

Beijing Social Science Fund 17GLC043Beijing Social Science Fund 17JDGLB008National Natural Science Foundation of China 71804009National Natural Science Foundation of China 71972012National Natural Science Foundation of China 71974011
6 · The paper itself

Abstract

The coronavirus SARS-CoV-2 emerging from Wuhan, China has developed into a global epidemic. Here, we combine both human mobility and non-pharmaceutical interventions (social-distancing and suspected-cases isolation) into SEIR transmission model to understand how coronavirus transmits in a global environment. Dynamic trends of region-specific time-variant reproduction number, social-distancing rate, work-resumption rate, and suspected-cases isolation rate have been estimated and plotted for each region by fitting stochastic transmission processes to the real total confirmed cases reported of each region. We find after shutdown in Wuhan, the reproduction number in Wuhan greatly declined from 6·982 (95% CI 2·558-14·668) on January 23rd, 2020 to 1.130 (95% CI 0.289-3.279) on February 7th, 2020, and there was a higher intervention level in terms of social-distancing and suspected-cases isolation in Wuhan than the Chinese average and Western average, for the period from the shutdown in Wuhan to mid-March. Future epidemic trajectories of Western countries up to October 10th, 2020, have been predicted with 95% confidence intervals. Through the scenario simulation, we discover the benefits of earlier international travel ban and rigorous intervention strategies, and the significance of non-pharmaceutical interventions. From a global perspective, it is vital for each country to control the risks of imported cases, and execute rigorous non-pharmaceutical interventions before successful vaccination development.

Indexed as

Models, StatisticalBasic Reproduction NumberCoronavirus InfectionsCOVID-19HumansPandemicsPneumonia, ViralQuarantine

Identifiers

PMID33110114
PMCPMC7591883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.